Scott Byrd Email

CEO . Sudo Biosciences

Menlo Park, CA

Location

s****@sudobio.com

Primary Email

Current Roles

Employees:
20
Revenue:
$1.6M
About
Sudo Biosciences is a biopharmaceutical company committed to designing and developing novel, best-in-class medicines to transform patients’ lives. Our lead programs target the tyrosine kinase 2 (TYK2) pseudokinase domain. TYK2 is a key mediator in cytokine signaling pathways that have been linked to a broad range of immune-mediated inflammatory conditions.
Sudo Biosciences Address
10401 N. Meridian St
Menlo Park, CA
Sudo Biosciences Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.